Nicotine isthe major addictive compound in tobacco and is responsible fortobacco dependence. It is primarily metabolized to cotinine (COT) and trans-3 1-hydroxycotinine (3HC) bythe liver enzyme cytochrome P-450 2A6 (CYP2A6). The 3HC/COT ratio measured in the saliva of smokers ishighly correlated with the intrinsic hepatic clearance of nicotine and,therefore, may be a useful non-invasive marker of CYP2A6 activity and metabolic rate of nicotine. This study assessed within-subject variation insalivary 3HC/COT ratios in six regular daily smokers. Our data provide evidence that 1. variation inthe 3HC/COT ratio isnot dependent on the time ofsampling during the day(i.e., morning vs. night) (P> 0.1) and 2. the average within-subject biological variation in the 3HC/COT ratioisapproximately 26%.These findings should be useful fordesigning large-scale population surveys to assess the variation in the metabolic rate of nicotine (via CYP2A6) insmokers.
Introduction
Nicotine is primarily responsible for initiation and maintenance ofcigarette smoking behavior. Smokers tend tosmoke a fairly consistent number of cigarettes from day to day, presumably to maintain the desired pharmacological effects of nicotine. The number ofcigarettes smoked per day and, thus, the level ofsystemic intake ofnicotine ispartly determined by therate at which nicotine ismetabolized (1, 2) . After nicotine is absorbed through the lungs it isprimarily (-80%) metabolized to cotinine (COT) and thentrans-3'-hydroxycotinine (3HC) by theliver enzyme cytochrome P-450 2A6 (CYP2A6) (2) . Nicotine clearance via CYP2A6 is known to vary significantly among subjects and different racial/ethnic groups (3, 4) . Variation in • Author10 whom com-spcndencc ..hould he .tddn-.....ed. t-rn.ul: Kod,ll',V@l"'lr,(fUI/ CYP2A6 activity may be an important factor influencing smoking initiation, degree ofdependence, ability to quit, and, thus, tobacco-induced disease risk (3) .
Variation inCYP2A6 enzyme activity isstrongly influenced by genetic factors with a heritability of-60% in Caucasians (5) . Several DNA sequence polymorphisms intheCYP2A6 gene are known toaffect therate ofmetabolism ofnicotine (6) . However, theutility oftheCYP2A6 genotype asa biomarker oftobacco dependence and susceptibility to smoking-related disease iscurrently limited. This isbecause thevariants identified to date account for relatively little ofthevariation in the metabolic rate ofnicotine (5) . This prompted Dempsey and colleagues (7) to investigate a non-invasive approach to phenotyping CYP2A6 activity. They showed that the ratio ofthe 3HC and COT concentration in saliva is highly correlated with the oral clearance of nicotine in smokers (r = 0.9), which in turn reflects intrinsic metabolic clearance ofnicotine by theliver via theCYP2A6 enzyme (7). These researchers proposed that the 3HC/COT ratio derived from a saliva sample isa reliable estimate ofCYP2A6 activity and, hence, an indicator oftherate ofhepatic metabolism ofnicotine.
The present study examines thewithin-subjects variation in thesalivary 3HC/COT ratio ina group ofregular smokers to assess the utility of this non-invasive measure for use in largescale population surveys ofthe metabolic rate ofnicotine.
Methods

Participants and sampling
For thisstudy, six regular daily smokers (five female and one male) were recruited from Wellington, New Zealand. The selfreported number ofcigarettes smoked onanaverage day for this group ranged from 5 to 20 cigarettes. Each participant was asked toprovide approximately 1-2mL ofsaliva ina sterile, airtight plastic collection tube twice a day for seven days. One saliva sample for each day was obtained first thing in the morning, prior to eating, drinking, or tooth brushing. The second sample was obtained in the evening justprior to going tosleep. Therefore, each participant provided a total of14 saliva samples for the 7-day period, allowing assessment ofwithin-and between-day variation in the 3HC/COT ratio. All saliva samples were self-obtained and were stored ina freezer in the participant's home until collection for analytical chemistry testing. Written informed consent was obtained for each subject. The study was approved by the Central Region Ethics Committee of New Zealand.
Analytical chemistry
Anon-smoker technician, living in a non-smoking environment, carried outall extractions. All glassware used inthe analysis was prerinsed with methanol to ensure that no COT was present. Saliva (0.5 mL) was pipetted into a prerinsed 7-mL silanized culture tube. Each sample was spiked with 50 )..IL ofinternal standards solution for COT and 3HC and covered immediately using caps with clean Teflon liners. The samples and standards were then vortex mixed briefly, and theinternal standards were allowed toequilibrate for 5 min. They were alkalinized with 0.5 mL 2.0M potassium carbonate, and then 3 mL ethyl acetate was added. The tubes were recapped and mixed for 15 min onthe vortex mixer. The tubes were centrifuged, and the ethyl acetate was transferred to clean culture tubes, which had been prerinsed with hexane. Glacial acetic acid (30 )..IL) was added to each tube, and then theethyl acetate was evaporated justto dryness ina Savant evaporator. The dry residue was reconstituted in 100 )..IL 10:90 acetonitrile/deionized water. The samples and standards were briefly vortex mixed and then sonicated for 10 min.
Analyses were conducted using a Shimadzu lOAVP high-performance liquid chromatography (HPLC) system attached toan Applied Biosystems API 300 Triple Quadrupole mass spectrometer equipped with a 'furboIonSpray ion" source. The HPLC column used was a Phenomenex SynergjTM 4-)..1 Polar (75 x 2.0-mm i.d.). The mobile phase was a gradient ofacetonitrile and 5mM ammonium acetate. The transitions monitored were 177/80 (180/80) for cotinine and 193/80 (196/80) for 3HC; the numbers in parentheses are the corresponding transitions for the respective internal standards.
Quantitation
The analyte concentrations in thesamples were determined using seven-point calibration lines with COT and 3HC concentrations ranging from 0to400 ng/ml, Linearity ofthecalibration lines was excellent, with typical r 2 values of0.999. The interday coefficients ofvariation (CVs) for COT and 3HC at 150 ng/rnl, were 1.8% and 3.3%, respectively, based onsix replicates on three different days. The corresponding accuracies were 102.4% and 100.8%, respectively.
Technical variation analysis
The variation insalivary 3HC/COT ratios attributable totechnical sources (i.e., variation because ofinstrument repeat determinations and sample storage temperature and duration) was assessed by spiking 0.5 mL of Barnstead H 2 0 with set concentrations of COT (52.5 nglmL) and 3HC (10 ng/rnl.).
Values were chosen to reflect physiological concentrations of the 3HC/COT ratios, and based on these values, the expected 3HC/COT ratio for a test sample was 0.19. For this experiment, four tests were conducted with a separate sample prepared for each test (4 x COT and 3HC suspended in H 2 0). Two ofthetestsamples were stored at room temperature (RT) and two samples were stored at -20°C. For each of the two storage temperatures, one sample was stored for one day and theother sample was stored for seven days. Duplicate HPLC measurements were subsequently taken for each ofthe four test samples.
Statistical analysis
CVs, thestandard deviation/mean x 100, were calculated to express therelative percent variability ofdata about themean. Independent i-tests were performed totest for differences inrepeat measures ofthe metabolic ratio or nicotine and the expected value inthetechnical variation experiment. Atwo-level repeated measures analysis ofvariance (ANOVA) was performed to assess within-and between-day variation in the measure. The Spearman's rho correlation coefficient and associated onetailed P-value was calculated to test for positive linear association between thenumber ofcigarettes smoked per day and the average metabolic ratio ofnicotine among smokers. AP-value of 0.05 was considered statistically significant. All statistical analyses were performed using SPSS V12 and graphs were generated using GraphPad Prism \It.
Results
Technical variation ofthe 3HC/COT ratio
Analysis oftechnical variation ofthesalivary 3HC/COT ratio comparing samples stored for 1and 7days at RT and -20°C was performed by calculating the mean oftheduplicate 3HC/COT ratios obtained for each ofthefour tests inthe experiment. The results indicate thatthere were minor differences between the observed means and the expected value (0.19) for both the storage temperature and duration tests. Comparing theduplicate data ofthe four test groups to0.19 did not provide evidence thatany ofthetest means were significantly different from the expected value (P > 0.1). The CVs derived for the four tests were 1.99%, 7.78%, 7.32%, and 3.54% for day 1 (RT), day 1 (-20°C), day 7 (RT), and day 7 (-20°C), respectively. The CV for all tests combined was 4.16%. This value isan estimate ofthe sum total of all technical variation (error) in the 3HC/COT ratio measurement.
Within-subject variation analysis
ANOVA was performed to assess whether variation in 3HC/COT ratios were dependent on daily time of sampling (i.e., a.m. vs p.m.). These data are presented in Table I sampling period did not differ significantly between a.m. or p.m. for these subjects, when considered independently orasa group (P> 0.01).
Because daily time ofsampling did notseem to have a significant effect on3HC/COT ratio in this group ofsmokers, we combined a.m. and p.m. values for each day togive average daily 3HC/COT ratios for each subject. These values were used toassess day-to-day variation for the six smokers as illustrated in Figure 1 . The CVs for the average daily 3HC/COT ratio for subjects 1-6were 19.4%, 16.6%, 18.8%,27.3%,32.3%, and 41.4%, respectively.
There was a moderately positive correlation between the number of cigarettes smoked per day and the average daily metabolic ratio ofnicotine, butthis was notstatistically significant for this small sample (r = 0.46, P= 0.18). 
Discussion
The metabolism of COT to 3HC is mediated primarily by the liver enzyme CYP2A6. (2) . The ratio of3HC/COT measured from saliva has been proposed as a non-invasive marker of CYP2A6 activity and, correspondingly, as a marker of the rate of nicotine metabolism (7) . The present study provides novel information on the storage procedure, circadian variability, and weekly variability of subjects in the 3HC/COT ratio measured in saliva. We provide evidence that 1. the 3HC/COT ratio is unaffected by storage at room temperature (as opposed to freezing) and unaffected by storage for up toseven days; 2.the 3HC/COT ratio isindependent ofthetime ofsampling during the day (i.e., morning vs. night); and 3. the 3HC/COT ratio isrelatively stable for subjects when measured daily over a one-week period.
The utility ofthe 3HC/COT ratio as a marker ofCYP2A6 activity isbased onthe idea thatconversion ofcotinine to3HC is a function ofCYP2A6 activity and thatthe elimination rate of 3HC isformation-limited. The latter factor isexpected because the half-life ofCOT isapproximately 16-18 h,and the half-life of3HC is 5h (8) . Because 3HC iseliminated much more rapidly than is its parent metabolite, COT, the levels of 3HC in the blood (or urine orsaliva) would be proportional toits formation rate and independent ofits own elimination rate. Thus, 3HC and COT levels would decline in parallel over time, and the ratio would remain constant.
There are several potential sources ofsubject variability inthe 3HC/COT ratio that should be considered. First isthatCYP2A6 activity may change over time, particularly inrelationship tothe effects offood, drugs, or other environmental exposures (2) . Second, because the conversion from COT to 3HC depends upon CYP2A6 activity inrelation toother competing clearance pathways (e.g., oxidation, glucuronidation, orrenal clearance), changes inthe clearance ofCOT via these competing pathways could also affect the ratio (2) . Third, the stability of the 3HC/COT ratio in subjects depends upon reaching a steady state. When a person isan occasional smoker or has changed their smoking rate markedly, the level of3HC may not have reached its steady state, and the ratio may be underestimated. Other sources ofvariability not investigated include the effects ofsaliva composition orflow rate onCOT or3HC levels and the stability ofactual saliva samples instorage.
The present study provides the first data assessing natural variation in the salivary 3HC/COT ratio in smokers. We have provided evidence that, for smokers with fairly constant smoking habits, 3HC/COT ratios do notvary significantly from morning to night and vary by about 26% from day-to-day. At this level ofwithin-subject variation, a reasonably good estimate of the true homeostatic value can be obtained from a single saliva sample. Our data, considered in conjunction with the previous findings ofDempsey etal. (7), suggest that the salivary 3HC/COT ratio as a non-invasive index ofCYP2A6 activity is useful for large-scale population surveys ofthe metabolic rate ofnicotine insmokers. One caveat with respect to the present study isthat the smokers we examined were generally moderate smokers, who smoked onaverage between 5 and 20 cigarettes per day. The ratio of3HC/COT might be more variable inlight 
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.. or occasional smokers. Thus, further investigation ofthestability ofthe ratio insuch smokers is needed.
